The Identification and Challenges of Dopamine Dysregulation Syndrome: A Case Report
Andrew Sulaiman, Idris Leppla

TL;DR
A man with Parkinson's disease and opioid use disorder exhibited signs of dopamine dysregulation syndrome, highlighting the challenges in managing this condition.
Contribution
This case report provides insight into the clinical presentation and management challenges of dopamine dysregulation syndrome in a complex patient.
Findings
The patient showed compulsive overuse of carbidopa/levodopa, consistent with dopamine dysregulation syndrome.
Despite increased medication frequency, the patient's symptoms persisted, leading to non-compliance and hospital discharge against medical advice.
The case emphasizes the need for integrated treatment of Parkinson's disease and substance use disorders in managing dopamine dysregulation syndrome.
Abstract
A 48-year-old man with a history of opioid use disorder (unmanaged) and presumed Parkinson's disease presented to the emergency department secondary to worsening of his Parkinson's tremors/ambulatory dysfunction. He expressed that he was taking up to 20 doses of his carbidopa/levodopa (25mg-250mg pills for a total of >5g levodopa every day). The patient was admitted for the management of Parkinson’s tremors and substance abuse. He was administered carbidopa/levodopa (25mg-250mg) every eight hours. Psychiatry was consulted due to marked functional fluctuations in his presentation and found that he demonstrated positive choreiform movements of the head/neck and upper extremity after taking the carbidopa. The patient's presentation prompted a suspicion of dopamine dysregulation syndrome (DDS). Supporting evidence included that the patient was insistent that the current regimen of…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsNeurological disorders and treatments · Attention Deficit Hyperactivity Disorder · Parkinson's Disease Mechanisms and Treatments
